S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
The Strategic Gold Play You Haven't Heard About (Ad)
3 Household Names With RSIs That Scream Oversold
The Odds Are High Costco Will Declare a Special Dividend Soon 
Windfall profits possible with this under-the-radar lithium stock. (Ad)
Stock market today: Global shares mostly fall over China worries
How You Can Reverse Engineer Michael Burry's Latest Buy
Windfall profits possible with this under-the-radar lithium stock. (Ad)
This Little Known Automaker May Save Your Life and Your Portfolio
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
The Strategic Gold Play You Haven't Heard About (Ad)
3 Household Names With RSIs That Scream Oversold
The Odds Are High Costco Will Declare a Special Dividend Soon 
Windfall profits possible with this under-the-radar lithium stock. (Ad)
Stock market today: Global shares mostly fall over China worries
How You Can Reverse Engineer Michael Burry's Latest Buy
Windfall profits possible with this under-the-radar lithium stock. (Ad)
This Little Known Automaker May Save Your Life and Your Portfolio
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
The Strategic Gold Play You Haven't Heard About (Ad)
3 Household Names With RSIs That Scream Oversold
The Odds Are High Costco Will Declare a Special Dividend Soon 
Windfall profits possible with this under-the-radar lithium stock. (Ad)
Stock market today: Global shares mostly fall over China worries
How You Can Reverse Engineer Michael Burry's Latest Buy
Windfall profits possible with this under-the-radar lithium stock. (Ad)
This Little Known Automaker May Save Your Life and Your Portfolio
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
The Strategic Gold Play You Haven't Heard About (Ad)
3 Household Names With RSIs That Scream Oversold
The Odds Are High Costco Will Declare a Special Dividend Soon 
Windfall profits possible with this under-the-radar lithium stock. (Ad)
Stock market today: Global shares mostly fall over China worries
How You Can Reverse Engineer Michael Burry's Latest Buy
Windfall profits possible with this under-the-radar lithium stock. (Ad)
This Little Known Automaker May Save Your Life and Your Portfolio
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
NYSE:HIMS

Hims & Hers Health (HIMS) Stock Forecast, Price & News

$6.22
+0.06 (+0.97%)
(As of 09/27/2023 ET)
Compare
Today's Range
$6.08
$6.32
50-Day Range
$6.02
$8.97
52-Week Range
$4.01
$12.34
Volume
1.27 million shs
Average Volume
1.92 million shs
Market Capitalization
$1.31 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.75

Hims & Hers Health MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.70 Rating Score
Upside/​Downside
88.9% Upside
$11.75 Price Target
Short Interest
Bearish
12.38% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.18mentions of Hims & Hers Health in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$2.25 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.15) to ($0.07) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.00 out of 5 stars

Medical Sector

629th out of 976 stocks

Offices & Clinics Of Medical Doctors Industry

3rd out of 7 stocks


HIMS stock logo

About Hims & Hers Health (NYSE:HIMS) Stock

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.

HIMS Price History

HIMS Stock News Headlines

2 Beauty Stocks Beaten By the Ugly Stick But Ready to Rally
Beauty stocks have not been pretty this year. Cosmetics retailer Ulta Beauty Inc. (NASDAQ: ULTA) and Estee Lauder Co. (NYSE: EL) shares
Hims & Hers Health: Can't Get Much Better
The Strategic Gold Play You Haven't Heard About
Experts recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure.
Hims & Hers Health, Inc. (NYSE:HIMS) CFO Sells $42,666.32 in Stock
Hims and Hers Stock Analysis: Buy or Sell?
Hims & Hers: Myopic Shorts, Absurdly Cheap
The Market Is Wrong On Hims & Hers Health
Would Buffett Approve of This Growth Strategy?
Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.
Hims & Hers Q2 Earnings: Portfolio Cure
Hims (ED) Review 2023
Q2 2023 Hims & Hers Health Inc Earnings Call
See More Headlines
Receive HIMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter.

HIMS Company Calendar

Last Earnings
8/07/2023
Today
9/28/2023
Next Earnings (Estimated)
11/06/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
651
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$11.75
High Stock Price Forecast
$18.00
Low Stock Price Forecast
$5.00
Forecasted Upside/Downside
+88.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.70
Research Coverage
10 Analysts

Profitability

Net Income
$-65,680,000.00
Pretax Margin
-6.58%

Debt

Sales & Book Value

Annual Sales
$526.92 million
Book Value
$1.50 per share

Miscellaneous

Free Float
144,276,000
Market Cap
$1.31 billion
Optionable
Optionable
Beta
0.53
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Andrew DudumMr. Andrew Dudum (Age 34)
    Co-Founder, Chairman & CEO
    Comp: $1.7M
  • Mr. Yemi Okupe (Age 37)
    Chief Financial Officer
    Comp: $804.05k
  • Ms. Melissa BairdMs. Melissa Baird (Age 45)
    Chief Operating Officer
    Comp: $917.67k
  • Ms. Irene A. Becklund (Age 38)
    Sr. VP, Controller & Principal Accounting Officer
    Comp: $361.12k
  • Ms. Soleil Teubner Boughton (Age 44)
    Chief Legal Officer & Corp. Sec.
    Comp: $782.66k
  • Mr. Mike Chi (Age 43)
    Chief Marketing Officer
    Comp: $514.77k
  • Dr. Patrick Carroll M.D. (Age 65)
    Chief Medical Officer, Member of Medical Advisory Board & Director
    Comp: $27.03k
  • Mr. Brian O'Shaughnessy
    Chief Communications Officer
  • Ms. Amee Parekh
    Sr. VP of HR
  • Mr. Jonathan Spitzer C.F.A.
    Sr. VP of Investor Relations













HIMS Stock - Frequently Asked Questions

Should I buy or sell Hims & Hers Health stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hims & Hers Health in the last year. There are currently 3 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" HIMS shares.
View HIMS analyst ratings
or view top-rated stocks.

What is Hims & Hers Health's stock price forecast for 2023?

10 brokers have issued 12-month target prices for Hims & Hers Health's stock. Their HIMS share price forecasts range from $5.00 to $18.00. On average, they predict the company's stock price to reach $11.75 in the next twelve months. This suggests a possible upside of 88.9% from the stock's current price.
View analysts price targets for HIMS
or view top-rated stocks among Wall Street analysts.

How have HIMS shares performed in 2023?

Hims & Hers Health's stock was trading at $6.41 at the beginning of the year. Since then, HIMS shares have decreased by 3.0% and is now trading at $6.22.
View the best growth stocks for 2023 here
.

Are investors shorting Hims & Hers Health?

Hims & Hers Health saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 16,650,000 shares, a decrease of 5.8% from the August 15th total of 17,680,000 shares. Based on an average daily trading volume, of 2,990,000 shares, the short-interest ratio is presently 5.6 days. Approximately 12.4% of the company's stock are short sold.
View Hims & Hers Health's Short Interest
.

When is Hims & Hers Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our HIMS earnings forecast
.

How were Hims & Hers Health's earnings last quarter?

Hims & Hers Health, Inc. (NYSE:HIMS) issued its earnings results on Monday, August, 7th. The company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.06) by $0.03. The business had revenue of $207.91 million for the quarter, compared to analyst estimates of $204.95 million. Hims & Hers Health had a negative net margin of 6.61% and a negative trailing twelve-month return on equity of 14.97%. The business's revenue was up 83.1% on a year-over-year basis. During the same period in the previous year, the company earned ($0.10) earnings per share.

What guidance has Hims & Hers Health issued on next quarter's earnings?

Hims & Hers Health issued an update on its third quarter 2023 earnings guidance on Monday, August, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $217.00 million-$222.00 million, compared to the consensus revenue estimate of $213.78 million.

What is Hims & Hers Health's stock symbol?

Hims & Hers Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HIMS."

Who are Hims & Hers Health's major shareholders?

Hims & Hers Health's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (4.74%), Marshall Wace LLP (2.78%), State Street Corp (1.42%), Nuveen Asset Management LLC (1.37%), Nuveen Asset Management LLC (1.37%) and Geode Capital Management LLC (1.13%). Insiders that own company stock include Alex Bard, Andrew Dudum, David B Wells, David B Wells, Irene Becklund, Jack Abraham, Jules A Maltz, Lynne Chou O'keefe, Melissa Baird, Oluyemi Okupe, Patrick Harrison Carroll, Soleil Boughton and Spencer Lee.
View institutional ownership trends
.

How do I buy shares of Hims & Hers Health?

Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hims & Hers Health's stock price today?

One share of HIMS stock can currently be purchased for approximately $6.22.

How much money does Hims & Hers Health make?

Hims & Hers Health (NYSE:HIMS) has a market capitalization of $1.31 billion and generates $526.92 million in revenue each year. The company earns $-65,680,000.00 in net income (profit) each year or ($0.22) on an earnings per share basis.

How many employees does Hims & Hers Health have?

The company employs 651 workers across the globe.

How can I contact Hims & Hers Health?

Hims & Hers Health's mailing address is 2269 CHESTNUT STREET SUITE 523, SAN FRANCISCO CA, 94123. The official website for the company is www.forhims.com. The company can be reached via phone at 415-851-0195 or via email at hims-ir@westwicke.com.

This page (NYSE:HIMS) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -